Status:
COMPLETED
A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects
Lead Sponsor:
ViiV Healthcare
Collaborating Sponsors:
Pfizer
Conditions:
Healthy
Eligibility:
All Genders
18-55 years
Phase:
PHASE4
Brief Summary
An open label study to evaluate an interaction between maraviroc and raltegravir in healthy subjects.
Detailed Description
Drug interaction study
Eligibility Criteria
Inclusion
- Healthy male and/or female subjects between 18 and 55 years of age.
Exclusion
- Evidence or history of clinically significant disease or clinical findings at screening
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00666705
Start Date
February 1 2008
End Date
March 1 2008
Last Update
January 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
New Haven, Connecticut, United States, 06511